VanEck Associates’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
VanEck Associates's BLUE Position: Q3 2020 in Review
VanEck Associates sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 3,321 shares — an estimated $2.63M sold.
VanEck Associates first reported a position in BLUE in Q3 2015 and held it in 20 quarters. The position peaked at $7.71M in Q3 2018. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.
- VanEck Associates reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
- VanEck Associates sold 3,321 bluebird bio shares in Q3 2020, an estimated $2.63M.
- VanEck Associates first reported a position in bluebird bio in Q3 2015 and held it in 20 quarters.
- VanEck Associates's bluebird bio position peaked at $7.71M in Q3 2018.
- 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.
Based on VanEck Associates's 13F filing for Q3 2020, filed 12 Nov 2020.